White-Label Genome Sequencing Deploys in 72 Hours

SCOTTSDALE, AZ – May 28, 2026 – GeneMetrics has positioned itself as a leading white-label whole genome sequencing platform for licensed health practitioners, clinic owners, and wellness brands looking to offer personalized genetic testing under their own identity. With a deployment window of 72 hours and HIPAA and GDPR compliance integrated throughout its infrastructure, the company allows practitioners to launch a branded genomics practice – covering patient-facing kits, lab processing, bioinformatics analysis, and clinically supported reports – without the need to build or manage any laboratory infrastructure independently.

Key Facts

• 72-hour launch window: Practitioners can move from a signed agreement to a fully branded, patient-ready genetic testing platform in as few as three business days.
• Whole genome to targeted panels: GeneMetrics supports sequencing options across the full spectrum – from 30x whole genome sequencing to targeted pharmacogenomics and wellness panels – under a single white-label contract.
• End-to-end fulfillment: Kit logistics, lab processing, bioinformatics pipelines, and report generation are all handled by GeneMetrics; the practitioner’s brand is the only name patients encounter.
• Multi-level data encryption with HIPAA and GDPR compliance: Data ownership remains with the practitioner and their patients – not with GeneMetrics – a structural distinction that sets this model apart from direct-to-consumer platforms.
• Scalable for any practice size: The platform accommodates solo integrative medicine practitioners, multi-location medical spas, supplement companies, and national health brands within the same infrastructure.
• Pharmacogenomics-ready: Practitioners can offer medication response testing – one of the fastest-growing segments in personalized medicine – without independent clinical laboratory registration.

The Problem No One Talks About at Conferences

Consider a scenario familiar to many integrative medicine physicians and functional health practitioners: a patient arrives with a folder of lab results, a history of adverse medication reactions, a supplement cabinet filled with products that “should” be working, and no clear answers. Standard bloodwork appears unremarkable. The patient is not imagining their symptoms. The information is simply absent from the panels being ordered.

That gap – between what conventional diagnostics can reveal and what a patient’s genome can explain – is where practitioners risk losing both clinical ground and patient confidence. For years, the barrier to closing that gap was infrastructure: the cost and complexity of establishing a CLIA-certified lab relationship, developing bioinformatics pipelines, and producing reports that carry clinical weight rather than functioning as consumer novelties.

GeneMetrics was built to remove that barrier entirely.

Beyond White-Label: What That Actually Means

Most white-label arrangements in genetic testing stop at placing a brand name on a PDF report. GeneMetrics operates under what it calls the Beyond-White-Label model – a framework that transfers not just brand aesthetics but full operational control to the practitioner. This includes bespoke report architecture, customizable panel configurations, and the ability to align sequencing depth with the clinical context of each patient population a practice serves.

That distinction carries real operational significance. A medical spa offering longevity and nutrigenomics panels has different reporting requirements than a psychiatric practice deploying pharmacogenomics testing for antidepressant selection. Both can be served within the same GeneMetrics infrastructure, with entirely distinct branded experiences and clinical outputs.

It is also worth noting that whole genome sequencing, while the most comprehensive option available, is not always the appropriate choice for every clinical context. Practitioners with focused diagnostic questions – drug metabolism, MTHFR pathway analysis, or specific ancestry-linked disease risk – often achieve clearer patient communication outcomes with targeted panels. GeneMetrics supports both approaches and advises practitioners on panel selection based on practice type and patient volume.

Executive Perspective

“The practitioners capturing growth in personalized medicine are not the ones building labs. They are the ones who understood early that their value is in the clinical relationship – and that the science can be delivered under their name without them owning the infrastructure. That is the entire premise of what we have built.” – GeneMetrics Executive Team

“Data ownership is not a feature we added. It is the architecture. When a patient’s genome lives in a system where the practitioner, not a consumer platform, holds the data relationship, that changes everything about consent, continuity of care, and trust. HIPAA and GDPR compliance are not optional layers – they are the minimum threshold, and we treat them accordingly.” – GeneMetrics Technical Leadership

About GeneMetrics

GeneMetrics provides white-label DNA and whole genome sequencing solutions that enable health professionals, clinics, and wellness brands to deliver fully branded genetic testing under their own name. The company manages all logistics, lab processing, bioinformatics, and report generation – allowing practitioners to offer personalized genetic insights without building laboratory infrastructure. GeneMetrics serves solo practitioners, medical spas, supplement companies, and national health brands, with deployments operational in as little as 72 hours. Learn more at genemetrics.com.

Contact Information:

GeneMetrics

Texas
Austin, Texas 78701
United States

Chris Haas
+1 1898202601
https://genemetrics.com